Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures
- 1 June 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 83, 106477
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 34 references indexed in Scilit:
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Epidemiology of Lung CancerChest, 2013
- USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesisJournal of Clinical Investigation, 2012
- MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation studyJournal of Cardiovascular Magnetic Resonance, 2012
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung AdenocarcinomasCancer Research, 2012
- Sparse kernel learning with LASSO and Bayesian inference algorithmNeural Networks, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and SurvivalPLOS ONE, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005